Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Lynch

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|February 1, 1993
OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trialK Höckerstedt, B G Ericzon, H Bismuth, et al.
Microbial Pathogenesis|June 24, 2010
Secretion of Pseudomonas aeruginosa type III cytotoxins is dependent on pseudomonas quinolone signal concentrationG Singh, B Wu, M S Baek, et al.
Surgery Today|January 1, 1994
The management and long-term results of Japanese pediatric liver transplant recipientsM Ishikawa, H Kitatani, T Akiyama, et al.
Transplantation Proceedings|October 1, 1994
Pediatric liver transplantation: delay in initiation of cyclosporine therapy beyond the immediate postoperative period does not adversely affect outcomeS V Lynch, J Yamanaka, G A Balderson, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2007
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilmsS V Lynch, L Dixon, M R Benoit, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|February 9, 2000
Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantationT Kubota, A Thomson, A D Clouston, et al.
Transplantation|October 27, 1994
A randomized trial of OKT3-based versus cyclosporine-based immunoprophylaxis after liver transplantation. Long-term results of a European and Australian multicenter studyO Farges, B G Ericzon, S Bresson-Hadni, et al.
Microbiome|January 13, 2021
Corroborating evidence refutes batch effect as explanation for fetal bacteriaE Rackaityte, J Halkias, E M Fukui, et al.
Nature Medicine|February 26, 2020
Viable bacterial colonization is highly limited in the human intestine in uteroE Rackaityte, J Halkias, E M Fukui, et al.
Transplantation|August 27, 1994
The value of the donor MEGX test in predicting liver allograft recipient outcomeJ M Potter, G A Balderson, P E Hickman, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|February 1, 1993
OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trialK Höckerstedt, B G Ericzon, H Bismuth, et al.
Microbial Pathogenesis|June 24, 2010
Secretion of Pseudomonas aeruginosa type III cytotoxins is dependent on pseudomonas quinolone signal concentrationG Singh, B Wu, M S Baek, et al.
Surgery Today|January 1, 1994
The management and long-term results of Japanese pediatric liver transplant recipientsM Ishikawa, H Kitatani, T Akiyama, et al.
Transplantation Proceedings|October 1, 1994
Pediatric liver transplantation: delay in initiation of cyclosporine therapy beyond the immediate postoperative period does not adversely affect outcomeS V Lynch, J Yamanaka, G A Balderson, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2007
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilmsS V Lynch, L Dixon, M R Benoit, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|February 9, 2000
Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantationT Kubota, A Thomson, A D Clouston, et al.
Transplantation|October 27, 1994
A randomized trial of OKT3-based versus cyclosporine-based immunoprophylaxis after liver transplantation. Long-term results of a European and Australian multicenter studyO Farges, B G Ericzon, S Bresson-Hadni, et al.
Microbiome|January 13, 2021
Corroborating evidence refutes batch effect as explanation for fetal bacteriaE Rackaityte, J Halkias, E M Fukui, et al.
Nature Medicine|February 26, 2020
Viable bacterial colonization is highly limited in the human intestine in uteroE Rackaityte, J Halkias, E M Fukui, et al.
Transplantation|August 27, 1994
The value of the donor MEGX test in predicting liver allograft recipient outcomeJ M Potter, G A Balderson, P E Hickman, et al.
Pageof 10